Sign Up
bf/NASDAQ:ATRA_icon.png

COM:ATARABIO

Atara Biotherapeutics Inc

  • Stock

Last Close

10.61

22/11 21:00

Market Cap

66.06M

Beta: -

Volume Today

65.66K

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.04
-
0.17
288.70%
0.05
69.33%
cash conversion cycle
1.70K
-
cash per share
7.51
-
20.88
177.99%
12.53
40.01%
8.90
28.96%
5.56
37.50%
7.07
27.07%
5.05
28.54%
6.77
34.02%
3.96
41.47%
2.38
39.90%
0.49
79.49%
company equity multiplier
-4.70
-
1.03
121.86%
1.03
0.28%
1.04
0.85%
1.22
17.72%
1.16
5.56%
1.18
1.99%
1.27
7.86%
1.67
31.61%
2.97
77.54%
-1.67
156.11%
days of inventory outstanding
398.68
-
days of payables outstanding
151.32
-
days of sales outstanding
17.69
-
230.93
1,205.13%
1.45K
528.84%
dividend yield
ebit per revenue
-16.74
-
-4.41
73.64%
-32.19
629.63%
ebt per ebit
1.00
-
1.00
0.31%
0.98
1.65%
0.97
0.64%
0.98
1.07%
0.97
1.04%
0.98
1.12%
0.99
0.82%
1.00
0.69%
0.81
18.53%
1.00
22.92%
effective tax rate
-0.02
-
0.00
104.51%
0.00
82.37%
-0.00
180.45%
0.00
192.59%
0.00
62.77%
-0.00
121.63%
-0.00
18.62%
-0.00
176.47%
-0.00
61.14%
-0.00
3.35%
enterprise value multiple
-2.50
-
-3.96
58.13%
-11.15
181.73%
-4.43
60.27%
-3.80
14.35%
-6.16
62.37%
-2.65
56.93%
-4.09
54.17%
-4.10
0.17%
-0.95
76.89%
-0.27
71.63%
fixed asset turnover
0.25
-
0.86
236.17%
0.15
82.95%
free cash flow per share
-0.87
-
-3.34
284.97%
-1.46
56.24%
-2.19
49.91%
-3.61
64.41%
-4.92
36.47%
-4.70
4.45%
-2.50
46.76%
-2.47
1.49%
-2.69
9.14%
-1.83
31.90%
gross profit margin
1
-
1
0%
-0.04
103.65%
interest coverage
-141.25
-
52.22
136.97%
inventory turnover
0.92
-
long term debt to capitalization
0.05
-
0.03
40.83%
0.08
204.85%
0.31
275.90%
-0.85
371.49%
net income per ebt
1.02
-
1.00
2.03%
1.00
0.07%
1.00
0.03%
1.00
0.02%
1.00
0.01%
1.00
0.02%
1.00
0.00%
1.00
0.01%
1.00
0.01%
1.00
0.00%
net profit margin
-16.72
-
-3.59
78.53%
-32.21
796.89%
operating cash flow per share
-0.87
-
-3.34
284.10%
-1.45
56.45%
-2.09
43.84%
-2.93
40.25%
-4.10
40.04%
-4.59
11.92%
-2.44
46.79%
-2.35
3.66%
-2.65
12.63%
-1.82
31.28%
operating cycle
1.85K
-
operating profit margin
-16.74
-
-4.41
73.64%
-32.19
629.63%
payables turnover
2.41
-
pretax profit margin
-16.72
-
-3.59
78.52%
-32.21
796.88%
price fair value
-6.64
-
1.29
119.46%
2.14
65.90%
1.61
25.01%
3.04
89.00%
4.49
47.80%
2.91
35.30%
3.14
8.07%
5.28
68.10%
2.64
49.97%
-0.55
120.72%
receivables turnover
20.63
-
1.58
92.34%
0.25
84.10%
return on assets
-0.17
-
-0.26
55.91%
-0.18
33.28%
-0.30
70.11%
-0.55
83.18%
-0.59
7.30%
-0.85
44.11%
-0.52
38.55%
-0.73
39.37%
-0.61
16.53%
-1.67
175.08%
return on capital employed
-0.17
-
-0.27
59.00%
-0.19
31.92%
-0.32
72.36%
-0.64
100.03%
-0.67
5.43%
-0.97
43.30%
-0.61
36.65%
-0.94
53.60%
-0.94
0.35%
-11.86
1,157.51%
return on equity
0.80
-
-0.27
134.08%
-0.18
33.09%
-0.31
71.56%
-0.67
115.64%
-0.68
1.34%
-1.00
46.98%
-0.66
33.73%
-1.22
83.43%
-1.80
48.20%
2.78
254.36%
total debt to capitalization
0.05
-
0.03
38.62%
0.09
191.72%
0.36
293.71%
-0.85
336.08%

All numbers in (except ratios and percentages)